Skip to Content

Neuberger Berman International Eq I NBIIX

Medalist Rating as of | See Neuberger Berman Investment Hub
  • NAV / 1-Day Return 12.63  /  −0.63 %
  • Total Assets 1.0 Bil
  • Adj. Expense Ratio
    0.870%
  • Expense Ratio 0.870%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category Foreign Large Blend
  • Investment Style Large Growth
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 2.10%
  • Turnover 41%

USD | NAV as of Feb 28, 2024 | 1-Day Return as of Feb 28, 2024, 11:16 PM GMT+0

Morningstar’s Analysis NBIIX

Will NBIIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Not beholden to a rigid style-box placement.

null Gregg Wolper

Gregg Wolper

Summary

Although this strategy won’t fit neatly into a strict style-box allocation, Neuberger Berman International Equity’s experienced team provides a thoughtful approach that stands out from most rivals.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings NBIIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 21.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

ASML Holding NV

3.44 35.1 Mil
Technology

AstraZeneca PLC

2.49 25.4 Mil
Healthcare

Sony Group Corp

2.35 24.0 Mil
Technology

Experian PLC

2.02 20.6 Mil
Industrials

Nestle SA

1.98 20.2 Mil
Consumer Defensive

London Stock Exchange Group PLC

1.85 18.9 Mil
Financial Services

Novartis AG Registered Shares

1.82 18.6 Mil
Healthcare

RELX PLC

1.74 17.8 Mil
Industrials

Roche Holding AG

1.73 17.7 Mil
Healthcare

Hitachi Ltd

1.72 17.6 Mil
Industrials